ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
Project Title | Institution / Principal Investigator(s) | Grant Type | Year | State |
---|---|---|---|---|
The Role of the Innate Immune System in Immune Dysregulation following CART | Children’s Hospital of Philadelphia / Caroline Diorio, MD | 'A' Award Grants | 2023 | Pennsylvania |
The Interplay Between Histone Mutations and Replication Stress in Shaping Glioma Phenotypes | Dana-Farber Cancer Institute / Pratiti Bandopadhayay, PhD | 'A' Award Grants | 2021 | Massachusetts |
A Role for Notch in Self-renewal in Embryonal Rhabdomyosarcoma | Massachusetts General Hospital / Myron Ignatius, PhD | 'A' Award Grants | 2012 | Massachusetts |
Mechanisms of PAX3-FOXO1 and HES3 Cooperation in Rhabdomyosarcoma | Nationwide Children’s Hospital / Genevieve Kendall, PhD | 'A' Award Grants | 2018 | Ohio |
IDO-based Immunotherapy for Pediatric Brain Tumors | Georgia Health Sciences University Research Institute, Inc. / Theodore Johnson, MD, PhD | 'A' Award Grants | 2013 | Georgia |
Genetic Susceptibility to Pediatric Osteosarcoma and Interaction with Measures of Childhood Growth | Duke University / Kyle Walsh, Ph.D. | 'A' Award Grants | 2014 | North Carolina |
The Role of Inherited MLL3 Single Nucleotide Variants and Fetal Epigenetic Programming in Infant Leukemogenesis | Washington University / Jeffrey Magee, MD/PhD | 'A' Award Grants | 2016 | Missouri |
An Engineered Nanoimmunotherapy for Treating Neuroblastoma | George Washington University / Rohan Fernandes, PhD | 'A' Award Grants | 2016 | District of Columbia |
Exploiting the Differentiation Potential of Pediatric High-Grade Glioma to Discover Novel Therapeutic Opportunities | Dana-Farber Cancer Institute / Mariella Filbin, MD/PhD | 'A' Award Grants | 2019 | Massachusetts |
Genetically Modified, Cord Blood Derived Natural Killer Cell Therapy for High Grade Pediatric Brain Tumors | Children’s Research Institute / Conrad Russell Cruz, MD, PhD | 'A' Award Grants | 2015 | District of Columbia |